EDAP TMS SA Asset Resilience Ratio
EDAP TMS SA asset resilience ratio. EDAP TMS SA (EDAP) has an Asset Resilience Ratio of 73.58% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See EDAP defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of EDAP TMS SA (2000–2023)
Asset resilience ratio of EDAP TMS SA from 2000 to 2023. This chart shows how EDAP TMS SA's Asset Resilience Ratio has changed over time. Read EDAP TMS SA debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down EDAP TMS SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of EDAP TMS SA.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $60.46 Million | 73.58% |
| Total Liquid Assets | $60.46 Million | 73.58% |
Asset Resilience Insights
- Very High Liquidity: EDAP TMS SA maintains exceptional liquid asset reserves at 73.58% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
EDAP TMS SA Industry Peers by Asset Resilience Ratio
Compare EDAP TMS SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.04% |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368 |
Medical Distribution | 1.77% |
|
ShareHope Medicine Co Ltd
TWO:8403 |
Medical Distribution | 3.61% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
EDAP TMS SA Asset Resilience Ratio by Year (2000–2023)
EDAP TMS SA asset resilience ratio by year from 2000 to 2023. The table below shows the annual Asset Resilience Ratio data for EDAP TMS SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 95.05% | $87.01 Million | $91.55 Million | -- |
| 2019-12-31 | 0.00% | $0.00 | $53.07 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $48.74 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $46.90 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $46.59 Million | -- |
| 2015-12-31 | 2.59% | $1.00 Million | $38.58 Million | -0.52pp |
| 2014-12-31 | 3.11% | $1.00 Million | $32.15 Million | -0.61pp |
| 2013-12-31 | 3.72% | $1.00 Million | $26.87 Million | +0.32pp |
| 2012-12-31 | 3.40% | $1.04 Million | $30.44 Million | -1.43pp |
| 2011-12-31 | 4.83% | $1.57 Million | $32.55 Million | +0.60pp |
| 2010-12-31 | 4.23% | $1.52 Million | $35.94 Million | +1.47pp |
| 2009-12-31 | 2.76% | $1.11 Million | $40.38 Million | +0.15pp |
| 2008-12-31 | 2.61% | $1.14 Million | $43.86 Million | +0.19pp |
| 2007-12-31 | 2.42% | $1.09 Million | $45.07 Million | -0.76pp |
| 2006-12-31 | 3.18% | $1.03 Million | $32.47 Million | +2.97pp |
| 2002-12-31 | 0.21% | $81.95K | $39.82 Million | -18.03pp |
| 2001-12-31 | 18.24% | $9.70 Million | $53.21 Million | -24.82pp |
| 2000-12-31 | 43.06% | $21.71 Million | $50.43 Million | -- |
About EDAP TMS SA
EDAP TMS S.A., a medical technology company, engages in the development, manufacturing, marketing, and sale of non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment de… Read more